Article info
Cervical Cancer
Sarcopenia Is an Important Prognostic Factor in Patients With Cervical Cancer Undergoing Concurrent Chemoradiotherapy
- Address correspondence and reprint requests to Keiichiro Nakamura, MD, PhD, Department of Obstetrics and Gynecology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, 2-5-1 Shikata-tyo, Kita-ku, Okayama 700-8558, Japan. E-mail: k-nakamu{at}cc.okayama-u.ac.jp.
Citation
Sarcopenia Is an Important Prognostic Factor in Patients With Cervical Cancer Undergoing Concurrent Chemoradiotherapy
Publication history
- Received June 22, 2017
- Accepted August 9, 2017
- First published January 1, 2018.
Online issue publication
June 18, 2019
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© 2018 by the International Gynecologic Cancer Society and the European Society of Gynaecological Oncology.